Company page

Dimerix Limited

Dimerix Limited (DXB) is a public company based in Australia with a market capitalization of approximately AUD 88.36 million. The company focuses on the development of innovative therapies for unmet medical needs, particularly in the areas of kidney disease and respiratory conditions. Dimerix is committed to advancing its clinical programs and expanding its portfolio of drug candidates.